chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The flu-like symptoms lasted only a couple days, as described in many places, but when that wore off, I became covered by a skin rash that itched profoundly.  My skin was covered with bumps and rash lesions from neck to ankles and the itching was unbearable.  I was finally put on prednisone that helped, but the rash returned when I tapered off.  After a while I was put on methylprednisolone long term.  I've been on it now seven months and though the dose is reduced, I have been unable to go off without itching breaking through.  My doctor thinks I have developed some kind of auto-immune disorder.
Pt called Call center on 4/23/21  regarding concerns about his symptoms. Pt complains of vomiting/nausea once a week since 1 and 1/2 month ago after eating and sometimes runny nose. Pt mentioned coming back from a trip out of the country on 3/25/21 and getting Johnson and Johnson vaccine on 4/9/21 and had concerns about the symptoms. Vomiting and nausea started before getting the vaccine and frequency didn't change afterwards. No doctor appt within 24 hrs at the time of call. Advised pt to go to ED.
his left hand is not functioning correctly, the sensation on his fingers is not the same as always and does not grip that well, he has weakness on his left hand; feeling down; a little sore at the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of DEPRESSED MOOD (feeling down), MUSCULAR WEAKNESS (his left hand is not functioning correctly, the sensation on his fingers is not the same as always and does not grip that well, he has weakness on his left hand) and VACCINATION SITE PAIN (a little sore at the injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LOSARTAN and MONTELUKAST for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE PAIN (a little sore at the injection site). On 15-Feb-2021, the patient experienced DEPRESSED MOOD (feeling down). On 16-Feb-2021, the patient experienced MUSCULAR WEAKNESS (his left hand is not functioning correctly, the sensation on his fingers is not the same as always and does not grip that well, he has weakness on his left hand). On 15-Feb-2021, DEPRESSED MOOD (feeling down) and VACCINATION SITE PAIN (a little sore at the injection site) had resolved. At the time of the report, MUSCULAR WEAKNESS (his left hand is not functioning correctly, the sensation on his fingers is not the same as always and does not grip that well, he has weakness on his left hand) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was unknown   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Updated the outcome of event left hand not functioning for several days (from unknown to recovered)
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from product quality group. The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Nov2021 as dose 3 (booster), single (Lot number: Ew0168), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PROZAC. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 29Oct2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29Oct2022) Positive, notes: took test and it was positive morning of 29Oct. Therapeutic measures were taken as a result of drug ineffective, covid-19. Course of events: Rebound covid after completing treatment. Symptoms started Friday 28Oct2022, took test and it was positive morning of 29Oct2022; Sender's Comments: Based on available information, a possible contributory role of the subject product BNT162b2 vaccine,  cannot be excluded for suspected LOE.   There is limited information provided in this report.  This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly
This is a spontaneous report from a contactable physician. A 71-years-old female patient of an unspecified ethnicity received PREVNAR 13, via an unspecified route of administration on left arm on an unspecified date at single dose. The patient medical history and concomitant medications were not reported. The patient experienced within 2 hours, injection site was red and swollen 2 cm and itchy. 5 days later she had itchy rashes on arms and neck. The outcome was unknown.
Starts to feel okay again, Able to breathe again, shoulder pain went away; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Starts to feel okay again, Able to breathe again, shoulder pain went away) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 and Shoulder pain.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Starts to feel okay again, Able to breathe again, shoulder pain went away). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Starts to feel okay again, Able to breathe again, shoulder pain went away) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Patient reported that four days after receiving the Moderna COVID-19 vaccination he starts to feel okay again, was able to breathe again and shoulder pain went away after he had it from COVID-19 before the shot. No treatment information was provided.
COVID19-PZIZER BIONTECH AUA Within less than 10 minutes after receiving Covid vaccine, patient developed red, flushed cheeks and headache.  Headache progressed to severe, describes as sharp, to back of head. B/P elevated to 164/118. Had patient to lie down in dark room. Rechecked B/P about 10 minutes later and improved to 145/107.  Pt. states no relief in headache and feels better is she is upright.  Recheck B/P again at 12:22 and 151/122. Pulse 86.  No shortness of breath or trouble breathing.  Denied any signs of anaphylaxsis. Had patient return to supine position and B/P improved to 130/90.  Continues to complian of headache.  Refuses to go to ER.  B/P rechecked at 1:10 pm and 140/100 while sitting. Advised of need to go to ER.
Painful red swelling occurring a couple of days after shot, extremely hot and approximately 3 inches surrounding area of injection site.  Benadryl and acetaminophen being taken at this time, swelling is declining in size but still painful to touch.
R deltoid swollen, area of 4" X 4" redness and warm to touch, noted 26 hours after injection. Child received Tylenol every 4 hrs. after injection on 4/11/06 X 3 doses, then 4 doses 8AM, 12PM and 4PM on 4/12/06. Saw FNP on 4/13. Tx: Benadryl and cold compresses.
improperly stored doses of vaccine administered; no adverse effect; This spontaneous report was received from a nurse refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. Nurse reported that on an unknown date,  the patient was administered an improperly stored doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (dosing details, route of administration unknown) lot # R004439 and expiry date 12-AUG-2019 for prophylaxis(product storage error).  Other concomitant therapy included sterile diluent which was properly stored. No adverse effect reported(no adverse event). There was no previous temperature excursion. The temperature was 26 degree Celsius or warmer and the time frame was 24 hours.
UNSPECIFIED ADVERSE EVENT; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced unspecified adverse event. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unspecified adverse event was not reported. This report was non-serious.
Shortly after receiving the vaccine I started noticing a strong random heartbeat approximately every minute.  At times strong heartbeat would occur several times a minute.  These symptoms have started to subside and are hardly noticeable today (11/6/23).  I have never had heart related issues.  As I have a Kardiamobile device for my husband I was able to document these random string heartbeats on 10/31/23.
Expired dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose). On 23-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Patient with 2 Pfizer vaccines who admitted with positive COVID PCR and complications from COVID.  Provider discharge note below:  "Patient is a 65-year-old male presented to the ER with hypoxia.  Patient was noted to have oxygen saturation of 83% room air.  He did have elevated D-dimer.  He was recently sick with COVID.  Patient was admitted with COVID pneumonia.  He did get his COVID vaccinations.  Later on with supportive care he was weaned off from oxygen.  He did have history of end-stage renal disease and his dialysis was continued.  His blood pressure medications were adjusted.  On discharge his blood sugars were borderline due to missing his meal.  Covering physician at the rehab facility need to monitor his blood sugars closely.  Otherwise patient has been stable."
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 4:28 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 4:28 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 67.90 for dose administered on 03-Apr-2021. No concomitant medications were reported.  Batch number 030B21A administered on 03-Apr-2021 underwent temperature excursion with temperature of 34 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 30-Mar-2021 and beyond use date for the vial was reported as 29-Apr-2021. Product moved to clinic on 03-Apr-2021.   Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.
12 hours after the shot was given, I started to have strong chills and weaknesses. Slept, woke up 6 hours later sweating with 102 fever and had a massive migraine. Extreme lethargy, fever, and headache lasted until 11 p.m. the day after the shot was given. All in all, time from when shot was given to end of symptoms: 35 hours, with the symptoms lasting 24 hours.
Felt dizzy this morning; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt dizzy this morning) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CALCIUM, COLECALCIFEROL (VITAMIN D 3), LISINOPRIL, ATORVASTATIN and GLIMEPIRIDE (GLIMEPIRID) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 11-Feb-2021, the patient experienced DIZZINESS (Felt dizzy this morning).   On 11-Feb-2021, DIZZINESS (Felt dizzy this morning) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Vaccine counseling performed by provider prior to vaccine administration by MA. Pt was alert and oriented. Provider left the room to see the next patient, however, was called back into the room after a few minutes by the MA d/t patient not feeling well after vaccine administration. When provider walked into exam room, pt was seated in a chair, appeared pale and somewhat diaphoretic. Pt stated that she was feeling dizzy and lightheaded. Pt was instructed to take deep breaths and was given a bottle of cold water to drink. Pt then verbalized that she was going to vomit. Pt vomited x 1. Pt then reported that she began to feel much better. Pts coloring returned and the diaphoresis abated. No LOC. Pts father was called to come pick patient up from the clinic. Parent arrived within 10 minutes. Patient and parent instructed to take pt to the ER if any adverse reactions occur after leaving clinic.  PE just prior to pt leaving clinic: CV, Lungs, and Neuro exam all WNL. Vitals taken just prior to patient leaving clinic: WNL. Patient stated that she felt much better and ambulated out of the clinic with her father without difficulty.
Redness and swelling developed around injection site, measuring 3.5 inches x 2.5 inches.
Team member states flu vaccine given too high on 9/22/22, does not feel was in deltoid muscle. Had immediate discomfort in left shoulder.  Pain increased that evening. Concerned for subacromial injection. Pain has continued without relief and has some limited movement.  Called Employee Health on 10/3/22, sent to Occupational Health for evaluation. 10/5/22 Went to occupational health, will return in 2 weeks.  Will continue with ibuprofen as needed and ROM exercises at home.
CHIEF COMPLAINT:   Pt tested covid+ 2 days ago. Pt reports room air spo2 88 at home. 84 on room air at triage. Pt denies CP, c/o sob. Spo2 to 90 on 6lpm.   HISTORY OF PRESENT ILLNESS:     Patient is a 53-year-old male with past medical history significant for hyperlipidemia who presents emergency room with complaints of hypoxia.  Patient reports he has been experiencing symptoms for 11 days, tested positive for COVID 2 days ago.  States when he was discharged from here he was given a pulse ox to monitor his symptoms at home.  States today his oxygen was 88 consistently and he could not bring it up with his breathing exercises.  States he does not feel very short of breath but noticed that and thought he should come in.  He denies any fever, chills, chest pain, nausea, vomiting, diarrhea, weakness or fatigue.  Patient is not currently on any medications for the COVID.  Denies any history of asthma, COPD, or seasonal allergies.  Patient is not a smoker.  Patient has not been vaccinated.
Headache; body aches; Trouble breathing; Had bleeding from her bottom; This is a spontaneous report from a contactable consumer (patient's parent). A 14-year-old female non-pregnant patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 13Jul2021 10:00 (14-year-old at time of vaccination) as single dose for COVID-19 immunisation. Medical history included asthma, JRA, migraines, blood pressure, and allergy to corn, beef, coconut, egg, coffee. The patient had no COVID-19 prior vaccination. Concomitant medication (other medications in two weeks) included vitamins nos (VITAMINS NOS) and unspecified medications for asthma, blood pressure, and migraine. The patient previously took amoxicillin and experienced allergy. There was no other vaccine in four weeks. Adverse event: The patient had headaches and body aches for 3 months. Trouble breathing, she has had ongoing medical issues since getting the vaccine. All her tests have came back normal so there is no reason for all the new medical issues. Only common factor is the Pfizer vaccine. She has been sick non stop since 13Jul2021. Including being hospitalized on 8/2- 8/5. She has not caught a break she is constantly sick and new medical issues popping up every other week. She had bleeding from her bottom while hospitalized. Adverse events started from 13Jul2021 10:30. Adverse events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, and hospitalization (from 02Aug2021 to 05Aug2021, while number of days hospitalization was reported as 5). The patient had to get an upper and lower endoscopy. COVID-19 was tested post vaccination: Nasal Swab on 02Aug2021 with result negative. Therapeutic measures were taken as a result of the events. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
AFTER RECIEVING IMMUNIZATIONS PT. DEVELOPED URTICARIA ON FACE, ARMS, AND LEGS. LUNGS CLEAR, NO WHEEZING OR BREATHING DIFFICULTIES.  ADVISED TO GIVE BENADRYL ALLERGY 1/2 TSP EVERY 6 HOURS AS NEEDED. ADVISED TO BE SEEN IMMEDIATELY IF COUGH, WHEEZE, OR BREATHING DIFFICULTIES.
Per mom that night Rt eyelid swollen went away in 2 days. No problems now.
Patient came to the pharmacy 2 days after the vaccines were administered to report that she was experiencing pain in her entire right upper arm and shoulder. The skin covering the side of her upper arm was red and warm to the touch. She also said she didn't "feel all that well" yesterday. She said she was fine on the day of the vaccine, but woke up the next day with the pain. Her arm looks and feels better today, and she feels fine today. I recommended cold compresses, BENADRYL and ibuprofen if needed. She said she would just "let it run it's course."
Severe muscle aches and pain High white count went to ER Patient is a 76 y.o. male who presents with pain.   Patient states on Friday he got a COVID booster to one deltoid and a flu shot in the other deltoid.  The next day patient developed pain basically from his legs up.  He has pain in his shoulders, his neck, his wrists.  Patient rates the pain in his right shoulder as 8 out of 10.  Patient has had pain in his right shoulder for quite a while got a steroid shot a while back that helped significantly but since the COVID and flu shot has had increased pain in his right shoulder.  Patient also with pain to his neck and pain to both wrists.  He rates these pains a 7 out of 10.  Patient reports that today his hands were slightly swollen.  Swelling is slightly better now.  The swelling and pain make it difficult for him to grip strongly.  Pain to his shoulder and wrist and hands his neck is worse with movement.  No fever.  No rash.   Patient is on Coumadin.  Last INR was December 28.  Therapeutic at 2.4.
Pt was previously vaccinated with FluAd on 8-25-2021 also.  Pt was vaccinated in clinic again on 9-14-21 with FluAd.  Pt has not had any symptoms or reactions.
Itching in mouth. Arms itching with rash. Felt as if throat was closing. BENADRYL 25 mg IM.